# US 2018/0021390 A1 · Prevotella histicola preparations and the treatment of autoimmune conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021390 A1
- Document ID: US20180021390A1
- Status: Published application
- Kind: A1
- Application number: 15/715,471
- Filed: 2017-09-26
- Published: 2018-01-25
- Earliest claimed: 2009-10-30
- Assignees: Mayo Foundation for Medical Education and Research
- Applicants: Mayo Foundation for Medical Education and Research
- Inventors: Joseph A. Murray; Eric V. Marietta; Susan H. Barton; Veena Taneja; Ashutosh Mangalam
- Web page: https://patentgrep.com/patent/US20180021390A1

## CPC

- A61K 35/74: Bacteria (therapeutic use of a bacterial protein A61K38/00)
- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 37/00: Drugs for immunological or allergic disorders
- C12N 1/205: Bacterial isolates
- A61K 9/00: Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations A61K49/18; preparations containing radioactive substances A61K51/12)}
- A61K 35/741: Probiotics (probiotic yeast, e.g. saccharomyces A61K36/06)
- C12R 2001/01: Bacteria or Actinomycetales {; using bacteria or Actinomycetales}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

This document provides methods and materials related to Prevotella histicola preparations. For example, Prevotella histicola preparations in the form of an oral medicament or dietary supplement (e.g., a pill, tablet, capsule) are provided. In addition, methods and materials for using a Prevotella histicola preparation provided herein as an anti-inflammatory agent are provided.

## Claims

### Claim 1

(canceled)

### Claim 2

A composition comprising:
(a) live Prevotella histicola, dead Prevotella histicola, or a culture supernatant of a Prevotella histicola culture,
(b) a buffer, a radical scavenger, an antioxidant, a reducing agent, or a mixture thereof, and
(c) a pharmaceutically acceptable carrier,
wherein said composition is in the form of a pill, a tablet, a powder, a liquid, or a capsule.

### Claim 3 (depends on 2)

The composition of claim 2, wherein said composition comprises said live Prevotella histicola.

### Claim 4 (depends on 3)

The composition of claim 3, wherein said composition contains between 1×107 to 1×1011 cells of said live Prevotella histicola.

### Claim 5 (depends on 2)

The composition of claim 2, wherein said composition comprises said dead Prevotella histicola.

### Claim 6 (depends on 5)

The composition of claim 5, wherein said composition contains between 1×107 to 1×1011 cells of said dead Prevotella histicola.

### Claim 7 (depends on 2)

The composition of claim 2, wherein said composition comprises said culture supernatant of said Prevotella histicola culture.

### Claim 8 (depends on 7)

The composition of claim 7, wherein said culture supernatant was obtained from said Prevotella histicola culture having greater than 1×107 cells of said Prevotella histicola per mL.

### Claim 9 (depends on 2)

The composition of claim 2, wherein said composition comprises said buffer.

### Claim 10 (depends on 2)

The composition of claim 2, wherein said composition comprises said radical scavenger.

### Claim 11 (depends on 2)

The composition of claim 2, wherein said composition comprises said antioxidant.

### Claim 12 (depends on 2)

The composition of claim 2, wherein said composition comprises said reducing agent.

### Claim 13 (depends on 2)

The composition of claim 2, wherein said composition comprises said mixture.

### Claim 14 (depends on 2)

The composition of claim 2, wherein said pharmaceutically acceptable carrier is a non-aqueous solvent.

### Claim 15 (depends on 14)

The composition of claim 14, wherein said non-aqueous solvent is propylene glycol, polyethylene glycol, a vegetable oil, or an organic ester.

### Claim 16 (depends on 2)

The composition of claim 2, wherein said composition is a pill, tablet, powder, or capsule.

### Claim 17 (depends on 16)

The composition of claim 16, wherein said pharmaceutically acceptable carrier is a non-aqueous solvent.

### Claim 18 (depends on 17)

The composition of claim 17, wherein said non-aqueous solvent is propylene glycol, polyethylene glycol, a vegetable oil, or an organic ester.

### Claim 19 (depends on 2)

The composition of claim 2, wherein said composition is a liquid.

### Claim 20 (depends on 19)

The composition of claim 19, wherein said pharmaceutically acceptable carrier is an aqueous carrier.

### Claim 21 (depends on 20)

The composition of claim 20, wherein said aqueous carrier is water, alcohol, saline, or a buffered solution.

### Claim 22 (depends on 2)

The composition of claim 2, wherein said composition is a pill.

### Claim 23 (depends on 2)

The composition of claim 2, wherein said live Prevotella histicola, said dead Prevotella histicola, or said culture supernatant is encapsulated in said pill to be released in the intestine of a mammal following oral administration of said pill to said mammal.

### Claim 24 (depends on 2)

The composition of claim 2, wherein said composition is a tablet.

### Claim 25 (depends on 2)

The composition of claim 2, wherein said live Prevotella histicola, said dead Prevotella histicola, or said culture supernatant is encapsulated in said tablet to be released in the intestine of a mammal following oral administration of said tablet to said mammal.

### Claim 26 (depends on 2)

The composition of claim 2, wherein said composition is a powder.

### Claim 27 (depends on 2)

The composition of claim 2, wherein said composition a capsule.

### Claim 28 (depends on 2)

The composition of claim 2, wherein said live Prevotella histicola, said dead Prevotella histicola, or said culture supernatant is encapsulated in said capsule to be released in the intestine of a mammal following oral administration of said capsule to said mammal.

### Claim 29 (depends on 2)

The composition of claim 2, wherein said live Prevotella histicola are live cells of the Prevotella histicola deposited as NRRL accession number B-50329, wherein said dead Prevotella histicola are dead Prevotella histicola deposited as NRRL accession number B-50329, and wherein said culture supernatant is a culture supernatant of a culture of the Prevotella histicola deposited as NRRL accession number B-50329.

### Claim 30 (depends on 2)

The composition of claim 2, wherein the pH of said composition is between about 6.5 and about 8.0.
